Ta strona została przetłumaczona automatycznie i dokładność tłumaczenia nie jest gwarantowana. Proszę odnieść się do angielska wersja za tekst źródłowy.

Reducing Pain-Related Sickness Absence Through Workplace Health Literacy: A Hybrid II Study

Prevention of Pain-Related Sickness Absence Through Organizational Workplace Health Literacy Intervention - A Hybrid II Study.

The primary aim of this study is investigate whether a workplace intervention targeting employees' and managers' understanding of pain and communication (called occupational health literacy) can reduce pain-related sick leave and help employees and managers to better understand and manage work-related health matters. The study also aims to learn how the program works, who it works best for (or not), and how it can be successfully used long-term in real workplaces, especially in production environments.

The study will e.g. examine whether the program:

  • reduces the number of sick days caused by pain,
  • lowers how much pain employees feel, and
  • improves employees' and managers' understanding of health and how to improve it.

Expectation:

Employees who participate in the program will:

  • take fewer sick days because of pain,
  • experience less pain, and have better health knowledge and skills than employees who continue with normal workplace practices.

The study will identify:

  • what makes the program difficult or easy to introduce at workplaces,
  • which strategies help it succeed, and
  • what factors make the program continue working over time.

Goal:

Help workplaces adopt and maintain the program successfully.

Przegląd badań

Status

Jeszcze nie rekrutacja

Warunki

Interwencja / Leczenie

Szczegółowy opis

The goal of this hybrid II randomized stepped wedge trial is to investigate if an organizational workplace health literacy intervention reduces pain-related sickness absence and pain intensity, and improves occupational health literacy - and to understand how and for whom the intervention can be successfully implemented and sustained in real-world workplaces within production sites.

  1. Effectiveness: To evaluate the effectiveness of the intervention on the primary outcome of pain-related sickness absence (days lost) and secondary outcomes of pain intensity and occupational health literacy.

    Hypothesis: Receiving the intervention will lead to fewer pain-related sickness absence days, lower pain intensity scores, and higher occupational health literacy compared to receiving usual care during the control condition/phase.

  2. Implementation - Barriers, Strategies and Mechanisms: To identify implementation barriers and targeted implementation strategies and to specify the underlying mechanisms of action supporting effective implementation and sustainability.

    Objective: To enhance local adoption, implementation and sustainability of the intervention.

  3. Implementation - Process: To provide an assessment of the implementation process, focusing on adoption, reach, fidelity, and sustainability across participating workplaces, and to identify contextual and processual factors that promote or hinder successful implementation.

Objective: Produce actionable implementation guidance and an evidence-informed strategy for broader roll-out and long-term maintenance.

A stepped-wedge design is a type of a crossover study in which clusters cross over from the control arm to the intervention arm at different randomized time points. The clusters will be formed based on working teams (consisting of approximately 15 workers), randomly assigned to a step (of implementation of the intervention) four months apart.

During the control phase/step, the participants receive standard care. In the workplace context, this implies that the control group can address work environment and health and safety issues through discussions within their health and safety organization. In Denmark, for workplaces with 10-34 employees, collaboration on health and safety is mandated to be organized within a health and safety organization, comprising one or more supervisors and one or more elected health and safety representatives, with the employer or a representative of the employer serving as chairman. This health and safety organization is tasked with both day-to-day and overarching responsibilities related to health and safety. Furthermore, workplaces or teams within the control group retain the option to seek assistance from trained work environment professionals external to their workplace if they choose to do so.

The intervention consists of 4 elements;

  1. A training day for the local workplace champion.
  2. Needs and resource assessment at the workplace
  3. Digital education in pain, communication and solutions for employees and managers
  4. Structured 1:1 dialogues between workers and their supervisor.

Method This project builds and extends upon a successful pilot of an organizational workplace health literacy (OWHL) intervention. Guided by the revised Medical Research Council (MRC) framework, the project aims to further develop, refine, and evaluate the effectiveness and implementation of the intervention and its core components to support the creation of a scalable workplace intervention suitable for implementation in production sites. The project will address the pilot study's limitations by

  1. randomizing to reduce bias,
  2. focus on an initial workplace needs assessment integrating a newly developed self-assessment workplace tool
  3. Integrating a cost-effective digital Educational Program, and
  4. tailoring implementation strategies to the particular target group and context/setting to ensure optimal uptake.

Addressing these limitations of the pilot study is essential to strengthen the validity of the findings and enhance the intervention's practical applicability.

Study setting and population The study population encompasses the 280.000 workers employed within production in Denmark, whereof 42 % are 50 years old, or older. This large working group is characterized by high physical and psychosocial work demands, with known potential challenges within safety communication between management and employees working the machines. Additionally, production workers experience around 10 days of sickness absence per year, report that they are overworked, and have elevated levels of pain, with a weekly pain prevalence of 43%. Consequently, this group is predisposed to an elevated risk of long-term sickness absence, and, in the most severe circumstances, premature withdrawal from the labor market.

Randomization and blinding To avoid contamination between workers, cluster randomization will performed, with each working team constituting a cluster. The randomization will be balanced on the size of the working teams. A blinded independent data manager will perform a computer-generated randomization. Blinding of participants is not possible, owing to the nature of the trial. Data collection will be performed using questionnares delivered through text messages, and data managers and research personnel collecting/handling data will be blinded to group allocation if deemed practically feasible.

Typ studiów

Interwencyjne

Zapisy (Szacowany)

193

Faza

  • Nie dotyczy

Kontakty i lokalizacje

Ta sekcja zawiera dane kontaktowe osób prowadzących badanie oraz informacje o tym, gdzie badanie jest przeprowadzane.

Kontakt w sprawie studiów

  • Nazwa: Mia Nyvang Stilling, PhD student
  • Numer telefonu: +4551795855
  • E-mail: mng@nfa.dk

Kopia zapasowa kontaktu do badania

  • Nazwa: Sebastian Venge Skovlund, PhD
  • E-mail: svs@nfa.dk

Kryteria uczestnictwa

Badacze szukają osób, które pasują do określonego opisu, zwanego kryteriami kwalifikacyjnymi. Niektóre przykłady tych kryteriów to ogólny stan zdrowia danej osoby lub wcześniejsze leczenie.

Kryteria kwalifikacji

Wiek uprawniający do nauki

  • Dorosły
  • Starszy dorosły

Akceptuje zdrowych ochotników

Tak

Opis

Inclusion criterias for the workplaces are:

  • each team needs a minimum of 15 employees
  • the work environment organization at the workplace wants to participate in the study. All employees and managers are invited to participate.

Exclusion Criteria:

  • There are no exclusion criterias for employees/managers

Plan studiów

Ta sekcja zawiera szczegółowe informacje na temat planu badania, w tym sposób zaprojektowania badania i jego pomiary.

Jak projektuje się badanie?

Szczegóły projektu

  • Główny cel: Zapobieganie
  • Przydział: Randomizowane
  • Model interwencyjny: Zadanie krzyżowe
  • Maskowanie: Pojedynczy

Broń i interwencje

Grupa uczestników / Arm
Interwencja / Leczenie
Eksperymentalny: Intervention group

The intervention group receives the described intervention targeting improved occupational health literacy, consisting of three components:

  1. A needs assessment
  2. Digital education
  3. Structured 1:1 dialogues between worker and supervisor

The main content of the intervention consists of 4 elements:

  1. An educational day session for the local workplace champion, with a main focus on the ability to faciliate a digital education for the employees and managers.
  2. An initial needs and resource assessment at the workplace focused on pain and health literacy, with participants from all organizational layers; employee, managers, HR and the workplace champion. The assessment aims to empower workplaces to self-assess their needs, contributing to own autonomy and direction. The session is facilitated by the researcher.
  3. 2*2 hours and 1*2 hour booster session of digital education for the employees and managers seperately, focusing on pain knowledge and communication, and finding solutions for work.
  4. A period of 4 months with structured 10-minutes 1:1 dialogues between an employee and the manager every 3-5 weeks, using the tools and communication from the educational content.
Inny: Control Group
While waiting for cross over, the control group can use available resources within the local working environment initiatives at the workplace.
While waiting for cross over, the control group can use available resources within the local working environment initiatives at the workplace.
Inne nazwy:
  • Grupa kontrolna

Co mierzy badanie?

Podstawowe miary wyniku

Miara wyniku
Opis środka
Ramy czasowe
Pain-related sickness absence
Ramy czasowe: The time frame will be from baseline to end of intervention at 16 weeks. Seeing that this is a stepped wedge RCT, baseline is before entering the control-period.
The primary outcome measure for effectiveness in this Hybrid 2 study, is self-reported pain-related sickness absence. Pain-related sickness absence will be assessed at baseline and every second week based on a questionnaire distributed by text messages to employees. The question to answer is: "In the last 4 weeks, how many days have you called in sick from work due to muscle pain?"
The time frame will be from baseline to end of intervention at 16 weeks. Seeing that this is a stepped wedge RCT, baseline is before entering the control-period.
Implementation appropriateness
Ramy czasowe: IAM is evaluated at 16 weeks, and through "Maintenance" 4 months after intervention end. Adoption and Implementation is evaluated after intervention end at 16 weeks.

The primary implementation outcome in this Hybrid 2 study is Appropriateness. Appropriateness is evaluated with the IAM- Intervention Appropriateness Measure. It consists of 4 items rated on a Likert scale (e.g., strongly disagree to strongly agree), with statements such as whether the intervention seems fitting, suitable, applicable, or a good match for the setting. The measure will be evaluated by the Workplace champions, employees and managers through telephone interviews after the interventions ends at 16 weeks.

Appropriateness is also explored through elements of the RE-AIM (secondary outcomes) evaluation (Adoption, Implementation and Maintenance) at 16 weeks through interviews (see secondary outcomes).

IAM is evaluated at 16 weeks, and through "Maintenance" 4 months after intervention end. Adoption and Implementation is evaluated after intervention end at 16 weeks.

Miary wyników drugorzędnych

Miara wyniku
Opis środka
Ramy czasowe
Pain intensity
Ramy czasowe: From baseline, before entering the stepped wedge control period, to the end of treatment at 16 weeks
Pain intensity of the participating employees will be self-assessed through a numeric range scale (NRS). The evaluation will be conducted through a questionnaire sent by a text message at baseline, once a month, and after the intervention has ended. The NRS consists of 0 to 10 scale, where 0 is equivalent to no pain, and 10 indicates the worst possible pain.
From baseline, before entering the stepped wedge control period, to the end of treatment at 16 weeks

Inne miary wyników

Miara wyniku
Opis środka
Ramy czasowe
Adoption
Ramy czasowe: Adoption is evaluated at the end of intervention, at 16 weeks.

The implementation adoption is evaluated through: How many workplaces express willingness to implement the health literacy intervention? This element is evaluated through interviews with HR and managers.

This approach ensures a comprehensive assessment of the study's adoption characteristics, contributing to a nuanced understanding of participant demographics and workplace contexts.

Adoption is evaluated at the end of intervention, at 16 weeks.
Organizational Workplace Health Literacy
Ramy czasowe: Organizational Workplace Health Literacy will be assessed at baseline, once a month and at the end of the intervention after 16weeks.

The Organizational Workplace Health Literacy will be assessed through a questionnaire that is currently under development at the NFA.

The questionnaire will consist of two inter-dependent parts answered on a 4 items rated on a Likert scale (e.g., strongly disagree to strongly agree): a part answered by an employee, and a part answered by a manager. Together, these two parts will express the level of Organizational Workplace Health Literacy within the local workplace. The evaluation will be conducted through a questionnaire sent by a text message at baseline, once a month, and after the intervention has ended.

Organizational Workplace Health Literacy will be assessed at baseline, once a month and at the end of the intervention after 16weeks.
Implementation fidelity
Ramy czasowe: Workplace champion, employees and managers will be interviewed at intervention end after 16 weeks.

Implementation fidelity will assess as to what extent the health literacy intervention is implemented according to the intended protocol, and what are the key factors influencing fidelity, including adherence to intervention components and the degree of customization to fit the diverse workplace contexts.

Implementation fidelity will be evaluated at three levels:

Workplace champion: The WEPs will undergo an educational day ahead of intervention start, with a main focus on the ability to facilitate the digital education. Implementation fidelity is assessed by questioning how and/or if the Workplace champions can facilitate the planned intervention elements. This is assessed through interviews.

Employees and managers: A part of the digital education will be to use communication tools when finding solutions to identified problems. Fidelity will be assessed through a questionnaire.

Workplace champion, employees and managers will be interviewed at intervention end after 16 weeks.
Cost evaluation
Ramy czasowe: Costs are collected continously throughout the project period.

The economic evaluation will compare the occupational health literacy intervention with usual care from the employer's perspective.

Staff time: Workers' and managers' participation in intervention activities (registration of participation in activities that are not directly part of daily work (e.g. a workshop/meeting for planning the activities)). Staff costs are referenced through Implementation Reach. Participants' and managers' costs will subsequently be valued based on their average yearly gross salaries, including overhead costs. Costs will include time and materials used to deliver the intervention, as well as costs from pain-related sickness absence and reduced productivity while at work (presenteeism).

Consumables: Materials (print-outs and posters) as well as fruit/snack/coffee at meetings will be assessed. These costs will be valued using invoices.

Results will be reported as cost-effectiveness, return on investment, and benefit-cost ratio.

Costs are collected continously throughout the project period.
Reach
Ramy czasowe: Reach will be documented continuously by the workplace champion and delivered for the researcher at intervention end, at 16 weeks.

Reach is evaluated through a workplace champion registrating in an Excel document the of number of partcipants pr. educational session. This document is shared with the researchers at the end of the intervention.

This will provide information about the adoption of the study. These registrations not only facilitate an understanding of the number of participants and workplaces involved but also provide essential details for characterizing the adoption (e.g., workplace size and type - public vs. private). This approach ensures a comprehensive assessment of the study's adoption characteristics, contributing to a nuanced understanding of participant demographics and workplace contexts.

Reach will be documented continuously by the workplace champion and delivered for the researcher at intervention end, at 16 weeks.
Implementation
Ramy czasowe: The interview will take place at the end of intervention, at 16 weeks.
Implementation will be evaluated through interviews of the workplace champions. These interviews, conducted via phone, Teams, or in-person workplace visits, will span 15-45 minutes and aim to gather comprehensive insights into the experiences of implementing and administering the intervention. The focus will be on understanding the factors contributing to the success or failure of implementation, exploring possibilities for sustainability, and informing future dissemination and implementation efforts if the intervention proves effective.
The interview will take place at the end of intervention, at 16 weeks.
Maintenance
Ramy czasowe: 4 months after the intervention has ended.
Maintenance is evaluated through interviews with managers and HR and will express how many workplaces sustain the outlined activities after interventions ends. When evaluating HR maintenance, there will also be a focus on which adaptions to workplace politics and policies there may have been made. These adaptions will be further explored by comparing the written action plans to HR being interviewed about the actual local adaptions.
4 months after the intervention has ended.

Współpracownicy i badacze

Tutaj znajdziesz osoby i organizacje zaangażowane w to badanie.

Sponsor

Współpracownicy

Daty zapisu na studia

Daty te śledzą postęp w przesyłaniu rekordów badań i podsumowań wyników do ClinicalTrials.gov. Zapisy badań i zgłoszone wyniki są przeglądane przez National Library of Medicine (NLM), aby upewnić się, że spełniają określone standardy kontroli jakości, zanim zostaną opublikowane na publicznej stronie internetowej.

Główne daty studiów

Rozpoczęcie studiów (Szacowany)

1 marca 2027

Zakończenie podstawowe (Szacowany)

1 marca 2028

Ukończenie studiów (Szacowany)

30 maja 2028

Daty rejestracji na studia

Pierwszy przesłany

3 lipca 2026

Pierwszy przesłany, który spełnia kryteria kontroli jakości

10 lipca 2026

Pierwszy wysłany (Rzeczywisty)

16 lipca 2026

Aktualizacje rekordów badań

Ostatnia wysłana aktualizacja (Rzeczywisty)

16 lipca 2026

Ostatnia przesłana aktualizacja, która spełniała kryteria kontroli jakości

10 lipca 2026

Ostatnia weryfikacja

1 lipca 2026

Więcej informacji

Terminy związane z tym badaniem

Inne numery identyfikacyjne badania

  • F-26029871
  • 186523 (Inny numer grantu/finansowania: TrygFonden)

Plan dla danych uczestnika indywidualnego (IPD)

Planujesz udostępniać dane poszczególnych uczestników (IPD)?

NIEZDECYDOWANY

Opis planu IPD

Data will immediately be assessed either collectively or based on the individual workplace.

Informacje o lekach i urządzeniach, dokumenty badawcze

Bada produkt leczniczy regulowany przez amerykańską FDA

Nie

Bada produkt urządzenia regulowany przez amerykańską FDA

Nie

Te informacje zostały pobrane bezpośrednio ze strony internetowej clinicaltrials.gov bez żadnych zmian. Jeśli chcesz zmienić, usunąć lub zaktualizować dane swojego badania, skontaktuj się z register@clinicaltrials.gov. Gdy tylko zmiana zostanie wprowadzona na stronie clinicaltrials.gov, zostanie ona automatycznie zaktualizowana również na naszej stronie internetowej .